GENE ONLINE|News &
Opinion
Blog

2025-11-29|

AI Utilized to Enhance Bioactive Compound Production in Medicinal Fungus Fomes fomentarius

by GOAI
Share To

Researchers have utilized artificial intelligence (AI) to optimize the bioactive potential of *Fomes fomentarius*, a type of medicinal fungus known for its therapeutic properties. The study, published on November 29, 2025, outlines how AI-assisted techniques were employed to enhance the production of bioactive compounds in this species, which has been traditionally used in natural medicine.

The research focused on identifying optimal conditions for maximizing the fungus’s beneficial properties. Using machine learning algorithms, scientists analyzed various environmental and cultivation factors that influence the production of bioactive compounds. These compounds are known for their antioxidant, antimicrobial, and anti-inflammatory effects. By applying AI-driven optimization methods, researchers were able to fine-tune these parameters more efficiently than traditional experimental approaches. The findings highlight advancements in integrating AI with biotechnology to improve natural product yields and applications.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top